Kenneth Galbraith sold $1.4M of Zymeworks (ZYME)

Executed Jan 5, disclosed Jan 5, the same day.

Value, as filed

$1.4M

54,343 sh across 2 lots

Executed

Jan 5

the trade date, as filed

Disclosed

Jan 5

0 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

KG Kenneth Galbraith Chair & CEO profile →

Kenneth Galbraith (Chair & CEO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in ZYME. The largest single filing was $1.4M of ZYME (54,343 sh across 2 lots, as filed), executed Jan 5.

The name

ZYME ZYME ZYME · 25 filings in 24 months ticker → Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Kenneth Galbraith in ZYME

ZYMESALE Zymeworks Inc. $690K
30,424 sh × $22.67
Exec Jan 12
Filed Jan 12 · 5:30 PM ET ZYMESALE Zymeworks Inc. $1.3M
47,528 sh × $27.02
Exec Dec 22 2025
Filed Dec 22 2025 · 5:30 PM ET ZYMESALE Zymeworks Inc. $855K
57,291 sh across 2 lots
Exec Jan 6 2025
Filed Jan 6 2025 · 5:30 PM ET